Filing Flows › Cumberland Pharmaceuticals (CPIX) › Vibativ revenue
Cumberland Pharmaceuticals (CPIX) Vibativ revenue by quarter
Cumberland Pharmaceuticals' Vibativ revenue was $1.7M in Q2 2026 (second quarter 2026), -18% from Q1 2026. Over the last 4 quarters it ranged from $1.7M (Q2 2026) to $2.7M (Q2 2025).
| Quarter | Vibativ revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $1.7M | -18% | -36% |
| Q1 2026 | $2.1M | -18% | — |
| Q3 2025 | $2.6M | -4% | — |
| Q2 2025 | $2.7M | — | — |
Q2 2026 at a glance
Cumberland Pharmaceuticals, Q2 2026: revenue $8.8M (-19% year over year), operating margin -35.9%, net loss $4.3M, operating cash flow $169K. The chart follows the revenue to costs, profit and cash.
Questions
What is Cumberland Pharmaceuticals' Vibativ revenue?
Cumberland Pharmaceuticals' Vibativ revenue was $1.7M in Q2 2026 (second quarter 2026), -18% from Q1 2026.
How has Cumberland Pharmaceuticals' Vibativ revenue changed?
Over the last 4 quarters it ranged from $1.7M (Q2 2026) to $2.7M (Q2 2025).
Q2 2026 results → · How Cumberland Pharmaceuticals makes money →